Funded Tech Companies
Nectin Therapeutics
Nectin Therapeutics is a biopharmaceutical company, based in Jerusalem. Financial backing was provided by Peregrine Ventures, private investors and aMoon Fund.
Company Overview
Company Name
Nectin Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Hi -Tech Campus Givat Ram POB 39135
Jerusalem, 91390
IL
Jerusalem, 91390
IL
Phone
Website
Email Address
Company Background Information
Overview
Nectin Therapeutics is a biotechnology company devoted to transforming the lives of cancer patients by pioneering the development of next generation immune oncology (IO) therapies. Our differentiated therapies have the potential to set new standards for efficacy and patient response rates across various difficult-to-treat cancers. The company was established in 2017 based on seminal research at the Hebrew University of Jerusalem and the University of Rijeka. Our technology addresses major escape mechanisms of current IO therapies through a diverse pipeline of novel monoclonal antibodies (mAbs) and antibody-drug-conjugates (ADCs).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/30/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fabian Tenenbaum
Chief Scientific Officer
Pini Tsukerman
VP - R & D
Guy Cinamon
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs